Company Filing History:
Years Active: 2012-2015
Title: The Innovations of James Swarbrick
Introduction
James Swarbrick is an accomplished inventor based in Pinehurst, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. With a total of 3 patents to his name, Swarbrick's work has the potential to improve therapeutic outcomes for patients.
Latest Patents
One of Swarbrick's notable inventions is the Threo-DOPS controlled release formulation. This invention relates to pharmaceutical formulations designed for the controlled delivery of threo-3-(3,4-dihydroxyphenyl)serine (threo-DOPS) and its derivatives. The formulation includes an extended or slow release component that maintains therapeutic concentrations of threo-DOPS in the blood plasma over an extended period. Additionally, it can be combined with an immediate release formulation to ensure steady levels of the active drug, thereby eliminating the sharp peaks and troughs in blood plasma drug levels that are often seen with existing threo-DOPS formulations.
Career Highlights
Throughout his career, James Swarbrick has worked with several prominent companies in the pharmaceutical industry. Notable among these are Chelsea Therapeutics, Inc. and Lundbeck NA Ltd. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.
Collaborations
Swarbrick has collaborated with various professionals in his field, including his coworker Stephen Peroutka. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical formulations.
Conclusion
James Swarbrick's contributions to the field of pharmaceuticals, particularly through his controlled release formulations, demonstrate his commitment to improving patient care. His innovative work continues to pave the way for advancements in drug delivery systems.